nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CAT—nephron—kidney cancer	0.0531	0.247	CbGeAlD
Fomepizole—ADH1C—nephron tubule—kidney cancer	0.0146	0.0679	CbGeAlD
Fomepizole—ADH1C—cortex of kidney—kidney cancer	0.0125	0.0581	CbGeAlD
Fomepizole—ADH1A—cardiac atrium—kidney cancer	0.0121	0.0564	CbGeAlD
Fomepizole—CAT—nephron tubule—kidney cancer	0.0115	0.0533	CbGeAlD
Fomepizole—CAT—renal system—kidney cancer	0.0104	0.0485	CbGeAlD
Fomepizole—CAT—kidney—kidney cancer	0.0101	0.0469	CbGeAlD
Fomepizole—CAT—cortex of kidney—kidney cancer	0.0098	0.0456	CbGeAlD
Fomepizole—ADH1B—renal system—kidney cancer	0.00938	0.0437	CbGeAlD
Fomepizole—CAT—gonad—kidney cancer	0.00934	0.0435	CbGeAlD
Fomepizole—CAT—cardiac atrium—kidney cancer	0.00932	0.0434	CbGeAlD
Fomepizole—CYP2E1—urine—kidney cancer	0.00915	0.0426	CbGeAlD
Fomepizole—ADH1B—kidney—kidney cancer	0.00907	0.0422	CbGeAlD
Fomepizole—ADH1B—cortex of kidney—kidney cancer	0.00883	0.0411	CbGeAlD
Fomepizole—ADH1B—gonad—kidney cancer	0.00841	0.0391	CbGeAlD
Fomepizole—ADH1B—cardiac atrium—kidney cancer	0.0084	0.0391	CbGeAlD
Fomepizole—CAT—Vinorelbine—Vincristine—kidney cancer	0.00546	0.372	CbGdCrCtD
Fomepizole—CAT—Vinorelbine—Vinblastine—kidney cancer	0.00546	0.372	CbGdCrCtD
Fomepizole—CAT—Vinblastine—Vincristine—kidney cancer	0.00375	0.256	CbGdCrCtD
Fomepizole—CYP2E1—nephron tubule—kidney cancer	0.00246	0.0115	CbGeAlD
Fomepizole—CYP2E1—renal system—kidney cancer	0.00224	0.0104	CbGeAlD
Fomepizole—CYP2E1—kidney—kidney cancer	0.00216	0.0101	CbGeAlD
Fomepizole—CYP2E1—cortex of kidney—kidney cancer	0.00211	0.00981	CbGeAlD
Fomepizole—Visual disturbance—Paclitaxel—kidney cancer	0.00131	0.00401	CcSEcCtD
Fomepizole—Dysgeusia—Everolimus—kidney cancer	0.00131	0.00399	CcSEcCtD
Fomepizole—Bradycardia—Sunitinib—kidney cancer	0.0013	0.00398	CcSEcCtD
Fomepizole—Somnolence—Temsirolimus—kidney cancer	0.0013	0.00397	CcSEcCtD
Fomepizole—Back pain—Everolimus—kidney cancer	0.00129	0.00394	CcSEcCtD
Fomepizole—Decreased appetite—Temsirolimus—kidney cancer	0.00127	0.00389	CcSEcCtD
Fomepizole—Nystagmus—Doxorubicin—kidney cancer	0.00127	0.00387	CcSEcCtD
Fomepizole—Vision blurred—Everolimus—kidney cancer	0.00126	0.00384	CcSEcCtD
Fomepizole—Pain—Temsirolimus—kidney cancer	0.00125	0.00382	CcSEcCtD
Fomepizole—Back pain—Erlotinib—kidney cancer	0.00125	0.0038	CcSEcCtD
Fomepizole—Anaemia—Vinblastine—kidney cancer	0.00124	0.00378	CcSEcCtD
Fomepizole—Flushing—Sorafenib—kidney cancer	0.00124	0.00377	CcSEcCtD
Fomepizole—Anaemia—Everolimus—kidney cancer	0.00123	0.00377	CcSEcCtD
Fomepizole—Agitation—Everolimus—kidney cancer	0.00123	0.00374	CcSEcCtD
Fomepizole—Somnolence—Pazopanib—kidney cancer	0.00123	0.00374	CcSEcCtD
Fomepizole—Dyspepsia—Pazopanib—kidney cancer	0.00122	0.00371	CcSEcCtD
Fomepizole—Vertigo—Vinblastine—kidney cancer	0.0012	0.00367	CcSEcCtD
Fomepizole—Pharyngitis—Dactinomycin—kidney cancer	0.0012	0.00367	CcSEcCtD
Fomepizole—Decreased appetite—Pazopanib—kidney cancer	0.0012	0.00366	CcSEcCtD
Fomepizole—Gastrointestinal pain—Temsirolimus—kidney cancer	0.0012	0.00365	CcSEcCtD
Fomepizole—Flushing—Sunitinib—kidney cancer	0.00119	0.00363	CcSEcCtD
Fomepizole—Phlebitis—Capecitabine—kidney cancer	0.00119	0.00362	CcSEcCtD
Fomepizole—Pain—Pazopanib—kidney cancer	0.00118	0.0036	CcSEcCtD
Fomepizole—Convulsion—Vinblastine—kidney cancer	0.00116	0.00354	CcSEcCtD
Fomepizole—Abdominal pain—Temsirolimus—kidney cancer	0.00116	0.00353	CcSEcCtD
Fomepizole—Body temperature increased—Temsirolimus—kidney cancer	0.00116	0.00353	CcSEcCtD
Fomepizole—Convulsion—Everolimus—kidney cancer	0.00116	0.00353	CcSEcCtD
Fomepizole—Dysgeusia—Sorafenib—kidney cancer	0.00114	0.00346	CcSEcCtD
Fomepizole—Anxiety—Everolimus—kidney cancer	0.00113	0.00346	CcSEcCtD
Fomepizole—Gastrointestinal pain—Pazopanib—kidney cancer	0.00113	0.00344	CcSEcCtD
Fomepizole—Flushing—Dactinomycin—kidney cancer	0.00113	0.00343	CcSEcCtD
Fomepizole—Anxiety—Erlotinib—kidney cancer	0.00109	0.00333	CcSEcCtD
Fomepizole—Dysgeusia—Sunitinib—kidney cancer	0.00109	0.00333	CcSEcCtD
Fomepizole—Abdominal pain—Pazopanib—kidney cancer	0.00109	0.00333	CcSEcCtD
Fomepizole—Back pain—Sunitinib—kidney cancer	0.00108	0.00329	CcSEcCtD
Fomepizole—Shock—Everolimus—kidney cancer	0.00107	0.00327	CcSEcCtD
Fomepizole—Anaemia—Sorafenib—kidney cancer	0.00107	0.00327	CcSEcCtD
Fomepizole—Tachycardia—Everolimus—kidney cancer	0.00106	0.00324	CcSEcCtD
Fomepizole—Shock—Erlotinib—kidney cancer	0.00104	0.00316	CcSEcCtD
Fomepizole—Anaemia—Sunitinib—kidney cancer	0.00103	0.00314	CcSEcCtD
Fomepizole—Pharyngitis—Gemcitabine—kidney cancer	0.00102	0.00311	CcSEcCtD
Fomepizole—Hypotension—Everolimus—kidney cancer	0.00102	0.00311	CcSEcCtD
Fomepizole—Diarrhoea—Temsirolimus—kidney cancer	0.001	0.00306	CcSEcCtD
Fomepizole—Anaemia—Dactinomycin—kidney cancer	0.000976	0.00298	CcSEcCtD
Fomepizole—Somnolence—Everolimus—kidney cancer	0.000969	0.00296	CcSEcCtD
Fomepizole—Dizziness—Temsirolimus—kidney cancer	0.000969	0.00296	CcSEcCtD
Fomepizole—Convulsion—Sunitinib—kidney cancer	0.000967	0.00295	CcSEcCtD
Fomepizole—Dyspepsia—Everolimus—kidney cancer	0.00096	0.00293	CcSEcCtD
Fomepizole—Decreased appetite—Vinblastine—kidney cancer	0.000951	0.0029	CcSEcCtD
Fomepizole—Decreased appetite—Everolimus—kidney cancer	0.000948	0.00289	CcSEcCtD
Fomepizole—Diarrhoea—Pazopanib—kidney cancer	0.000945	0.00288	CcSEcCtD
Fomepizole—Pain—Vinblastine—kidney cancer	0.000936	0.00285	CcSEcCtD
Fomepizole—Pain—Everolimus—kidney cancer	0.000932	0.00284	CcSEcCtD
Fomepizole—Vomiting—Temsirolimus—kidney cancer	0.000932	0.00284	CcSEcCtD
Fomepizole—Shock—Sorafenib—kidney cancer	0.000931	0.00284	CcSEcCtD
Fomepizole—Dyspepsia—Erlotinib—kidney cancer	0.000926	0.00282	CcSEcCtD
Fomepizole—Rash—Temsirolimus—kidney cancer	0.000924	0.00282	CcSEcCtD
Fomepizole—Dermatitis—Temsirolimus—kidney cancer	0.000923	0.00282	CcSEcCtD
Fomepizole—Headache—Temsirolimus—kidney cancer	0.000918	0.0028	CcSEcCtD
Fomepizole—Decreased appetite—Erlotinib—kidney cancer	0.000915	0.00279	CcSEcCtD
Fomepizole—Dizziness—Pazopanib—kidney cancer	0.000913	0.00278	CcSEcCtD
Fomepizole—Back pain—Vincristine—kidney cancer	0.000913	0.00278	CcSEcCtD
Fomepizole—Hiccups—Doxorubicin—kidney cancer	0.000907	0.00277	CcSEcCtD
Fomepizole—Pain—Erlotinib—kidney cancer	0.0009	0.00274	CcSEcCtD
Fomepizole—Shock—Sunitinib—kidney cancer	0.000896	0.00273	CcSEcCtD
Fomepizole—Gastrointestinal pain—Vinblastine—kidney cancer	0.000895	0.00273	CcSEcCtD
Fomepizole—Gastrointestinal pain—Everolimus—kidney cancer	0.000892	0.00272	CcSEcCtD
Fomepizole—Vomiting—Pazopanib—kidney cancer	0.000878	0.00268	CcSEcCtD
Fomepizole—Bradycardia—Paclitaxel—kidney cancer	0.000877	0.00267	CcSEcCtD
Fomepizole—Anaemia—Vincristine—kidney cancer	0.000872	0.00266	CcSEcCtD
Fomepizole—Rash—Pazopanib—kidney cancer	0.000871	0.00265	CcSEcCtD
Fomepizole—Nausea—Temsirolimus—kidney cancer	0.000871	0.00265	CcSEcCtD
Fomepizole—Dermatitis—Pazopanib—kidney cancer	0.00087	0.00265	CcSEcCtD
Fomepizole—Agitation—Vincristine—kidney cancer	0.000867	0.00264	CcSEcCtD
Fomepizole—Back pain—Gemcitabine—kidney cancer	0.000866	0.00264	CcSEcCtD
Fomepizole—Abdominal pain—Vinblastine—kidney cancer	0.000865	0.00264	CcSEcCtD
Fomepizole—Headache—Pazopanib—kidney cancer	0.000865	0.00264	CcSEcCtD
Fomepizole—Abdominal pain—Everolimus—kidney cancer	0.000862	0.00263	CcSEcCtD
Fomepizole—Body temperature increased—Everolimus—kidney cancer	0.000862	0.00263	CcSEcCtD
Fomepizole—Gastrointestinal pain—Erlotinib—kidney cancer	0.00086	0.00262	CcSEcCtD
Fomepizole—Pharyngitis—Paclitaxel—kidney cancer	0.000855	0.00261	CcSEcCtD
Fomepizole—Vertigo—Vincristine—kidney cancer	0.000848	0.00259	CcSEcCtD
Fomepizole—Dyspepsia—Sorafenib—kidney cancer	0.000833	0.00254	CcSEcCtD
Fomepizole—Body temperature increased—Erlotinib—kidney cancer	0.000832	0.00254	CcSEcCtD
Fomepizole—Abdominal pain—Erlotinib—kidney cancer	0.000832	0.00254	CcSEcCtD
Fomepizole—Visual impairment—Paclitaxel—kidney cancer	0.00083	0.00253	CcSEcCtD
Fomepizole—Anaemia—Gemcitabine—kidney cancer	0.000828	0.00252	CcSEcCtD
Fomepizole—Decreased appetite—Sorafenib—kidney cancer	0.000823	0.00251	CcSEcCtD
Fomepizole—Nausea—Pazopanib—kidney cancer	0.00082	0.0025	CcSEcCtD
Fomepizole—Convulsion—Vincristine—kidney cancer	0.000818	0.00249	CcSEcCtD
Fomepizole—Pain—Sorafenib—kidney cancer	0.000809	0.00247	CcSEcCtD
Fomepizole—Dyspepsia—Sunitinib—kidney cancer	0.000802	0.00244	CcSEcCtD
Fomepizole—Flushing—Paclitaxel—kidney cancer	0.000799	0.00244	CcSEcCtD
Fomepizole—Decreased appetite—Sunitinib—kidney cancer	0.000792	0.00241	CcSEcCtD
Fomepizole—Pain—Sunitinib—kidney cancer	0.000779	0.00237	CcSEcCtD
Fomepizole—Gastrointestinal pain—Sorafenib—kidney cancer	0.000774	0.00236	CcSEcCtD
Fomepizole—Phlebitis—Doxorubicin—kidney cancer	0.000764	0.00233	CcSEcCtD
Fomepizole—Decreased appetite—Dactinomycin—kidney cancer	0.000749	0.00229	CcSEcCtD
Fomepizole—Diarrhoea—Vinblastine—kidney cancer	0.000749	0.00228	CcSEcCtD
Fomepizole—Body temperature increased—Sorafenib—kidney cancer	0.000748	0.00228	CcSEcCtD
Fomepizole—Abdominal pain—Sorafenib—kidney cancer	0.000748	0.00228	CcSEcCtD
Fomepizole—Diarrhoea—Everolimus—kidney cancer	0.000746	0.00227	CcSEcCtD
Fomepizole—Gastrointestinal pain—Sunitinib—kidney cancer	0.000745	0.00227	CcSEcCtD
Fomepizole—Pain—Dactinomycin—kidney cancer	0.000737	0.00225	CcSEcCtD
Fomepizole—Dysgeusia—Paclitaxel—kidney cancer	0.000734	0.00224	CcSEcCtD
Fomepizole—Back pain—Paclitaxel—kidney cancer	0.000725	0.00221	CcSEcCtD
Fomepizole—Dizziness—Vinblastine—kidney cancer	0.000724	0.00221	CcSEcCtD
Fomepizole—Dizziness—Everolimus—kidney cancer	0.000721	0.0022	CcSEcCtD
Fomepizole—Body temperature increased—Sunitinib—kidney cancer	0.00072	0.0022	CcSEcCtD
Fomepizole—Abdominal pain—Sunitinib—kidney cancer	0.00072	0.0022	CcSEcCtD
Fomepizole—Diarrhoea—Erlotinib—kidney cancer	0.00072	0.00219	CcSEcCtD
Fomepizole—Hypotension—Vincristine—kidney cancer	0.00072	0.00219	CcSEcCtD
Fomepizole—Bradycardia—Capecitabine—kidney cancer	0.000719	0.00219	CcSEcCtD
Fomepizole—Vision blurred—Paclitaxel—kidney cancer	0.000706	0.00215	CcSEcCtD
Fomepizole—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000705	0.00215	CcSEcCtD
Fomepizole—Pharyngitis—Capecitabine—kidney cancer	0.000701	0.00214	CcSEcCtD
Fomepizole—Vomiting—Vinblastine—kidney cancer	0.000696	0.00212	CcSEcCtD
Fomepizole—Dizziness—Erlotinib—kidney cancer	0.000696	0.00212	CcSEcCtD
Fomepizole—Vomiting—Everolimus—kidney cancer	0.000693	0.00211	CcSEcCtD
Fomepizole—Anaemia—Paclitaxel—kidney cancer	0.000693	0.00211	CcSEcCtD
Fomepizole—Agitation—Paclitaxel—kidney cancer	0.000689	0.0021	CcSEcCtD
Fomepizole—Rash—Everolimus—kidney cancer	0.000687	0.0021	CcSEcCtD
Fomepizole—Dermatitis—Everolimus—kidney cancer	0.000687	0.00209	CcSEcCtD
Fomepizole—Headache—Vinblastine—kidney cancer	0.000686	0.00209	CcSEcCtD
Fomepizole—Headache—Everolimus—kidney cancer	0.000683	0.00208	CcSEcCtD
Fomepizole—Hypotension—Gemcitabine—kidney cancer	0.000683	0.00208	CcSEcCtD
Fomepizole—Body temperature increased—Dactinomycin—kidney cancer	0.000682	0.00208	CcSEcCtD
Fomepizole—Abdominal pain—Dactinomycin—kidney cancer	0.000682	0.00208	CcSEcCtD
Fomepizole—Visual impairment—Capecitabine—kidney cancer	0.000681	0.00208	CcSEcCtD
Fomepizole—Vertigo—Paclitaxel—kidney cancer	0.000674	0.00205	CcSEcCtD
Fomepizole—Decreased appetite—Vincristine—kidney cancer	0.00067	0.00204	CcSEcCtD
Fomepizole—Vomiting—Erlotinib—kidney cancer	0.000669	0.00204	CcSEcCtD
Fomepizole—Rash—Erlotinib—kidney cancer	0.000663	0.00202	CcSEcCtD
Fomepizole—Dermatitis—Erlotinib—kidney cancer	0.000663	0.00202	CcSEcCtD
Fomepizole—Headache—Erlotinib—kidney cancer	0.000659	0.00201	CcSEcCtD
Fomepizole—Pain—Vincristine—kidney cancer	0.000659	0.00201	CcSEcCtD
Fomepizole—Flushing—Capecitabine—kidney cancer	0.000656	0.002	CcSEcCtD
Fomepizole—Nausea—Vinblastine—kidney cancer	0.00065	0.00198	CcSEcCtD
Fomepizole—Somnolence—Gemcitabine—kidney cancer	0.00065	0.00198	CcSEcCtD
Fomepizole—Convulsion—Paclitaxel—kidney cancer	0.000649	0.00198	CcSEcCtD
Fomepizole—Nausea—Everolimus—kidney cancer	0.000648	0.00197	CcSEcCtD
Fomepizole—Diarrhoea—Sorafenib—kidney cancer	0.000648	0.00197	CcSEcCtD
Fomepizole—Anxiety—Paclitaxel—kidney cancer	0.000636	0.00194	CcSEcCtD
Fomepizole—Decreased appetite—Gemcitabine—kidney cancer	0.000635	0.00194	CcSEcCtD
Fomepizole—Gastrointestinal pain—Vincristine—kidney cancer	0.00063	0.00192	CcSEcCtD
Fomepizole—Dizziness—Sorafenib—kidney cancer	0.000626	0.00191	CcSEcCtD
Fomepizole—Pain—Gemcitabine—kidney cancer	0.000625	0.00191	CcSEcCtD
Fomepizole—Nausea—Erlotinib—kidney cancer	0.000625	0.00191	CcSEcCtD
Fomepizole—Diarrhoea—Sunitinib—kidney cancer	0.000623	0.0019	CcSEcCtD
Fomepizole—Body temperature increased—Vincristine—kidney cancer	0.000609	0.00186	CcSEcCtD
Fomepizole—Abdominal pain—Vincristine—kidney cancer	0.000609	0.00186	CcSEcCtD
Fomepizole—Dysgeusia—Capecitabine—kidney cancer	0.000602	0.00184	CcSEcCtD
Fomepizole—Dizziness—Sunitinib—kidney cancer	0.000602	0.00184	CcSEcCtD
Fomepizole—Shock—Paclitaxel—kidney cancer	0.000602	0.00184	CcSEcCtD
Fomepizole—Vomiting—Sorafenib—kidney cancer	0.000602	0.00183	CcSEcCtD
Fomepizole—Tachycardia—Paclitaxel—kidney cancer	0.000597	0.00182	CcSEcCtD
Fomepizole—Rash—Sorafenib—kidney cancer	0.000597	0.00182	CcSEcCtD
Fomepizole—Dermatitis—Sorafenib—kidney cancer	0.000596	0.00182	CcSEcCtD
Fomepizole—Back pain—Capecitabine—kidney cancer	0.000595	0.00181	CcSEcCtD
Fomepizole—Headache—Sorafenib—kidney cancer	0.000593	0.00181	CcSEcCtD
Fomepizole—Diarrhoea—Dactinomycin—kidney cancer	0.00059	0.0018	CcSEcCtD
Fomepizole—ADH1C—Metabolism—GLIPR1—kidney cancer	0.000581	0.00131	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PPAT—kidney cancer	0.000581	0.00131	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PPAT—kidney cancer	0.000581	0.00131	CbGpPWpGaD
Fomepizole—Vision blurred—Capecitabine—kidney cancer	0.00058	0.00177	CcSEcCtD
Fomepizole—Vomiting—Sunitinib—kidney cancer	0.000579	0.00177	CcSEcCtD
Fomepizole—Body temperature increased—Gemcitabine—kidney cancer	0.000578	0.00176	CcSEcCtD
Fomepizole—CYP2E1—Vitamin A and Carotenoid Metabolism—SCARB1—kidney cancer	0.000575	0.0013	CbGpPWpGaD
Fomepizole—Rash—Sunitinib—kidney cancer	0.000574	0.00175	CcSEcCtD
Fomepizole—Dermatitis—Sunitinib—kidney cancer	0.000574	0.00175	CcSEcCtD
Fomepizole—Hypotension—Paclitaxel—kidney cancer	0.000572	0.00174	CcSEcCtD
Fomepizole—Headache—Sunitinib—kidney cancer	0.000571	0.00174	CcSEcCtD
Fomepizole—Anaemia—Capecitabine—kidney cancer	0.000569	0.00173	CcSEcCtD
Fomepizole—Eosinophilia—Doxorubicin—kidney cancer	0.000563	0.00172	CcSEcCtD
Fomepizole—Nausea—Sorafenib—kidney cancer	0.000562	0.00171	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CCBL1—kidney cancer	0.000555	0.00125	CbGpPWpGaD
Fomepizole—Vertigo—Capecitabine—kidney cancer	0.000553	0.00169	CcSEcCtD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—kidney cancer	0.000549	0.00124	CbGpPWpGaD
Fomepizole—Vomiting—Dactinomycin—kidney cancer	0.000548	0.00167	CcSEcCtD
Fomepizole—Somnolence—Paclitaxel—kidney cancer	0.000544	0.00166	CcSEcCtD
Fomepizole—Rash—Dactinomycin—kidney cancer	0.000544	0.00166	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—HIF1A—kidney cancer	0.000541	0.00122	CbGpPWpGaD
Fomepizole—Nausea—Sunitinib—kidney cancer	0.000541	0.00165	CcSEcCtD
Fomepizole—ADH1C—Metabolism—FH—kidney cancer	0.00054	0.00122	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—APRT—kidney cancer	0.00054	0.00122	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—FH—kidney cancer	0.00054	0.00122	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—APRT—kidney cancer	0.00054	0.00122	CbGpPWpGaD
Fomepizole—Dyspepsia—Paclitaxel—kidney cancer	0.000539	0.00164	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MYC—kidney cancer	0.000533	0.0012	CbGpPWpGaD
Fomepizole—Decreased appetite—Paclitaxel—kidney cancer	0.000532	0.00162	CcSEcCtD
Fomepizole—Diarrhoea—Vincristine—kidney cancer	0.000527	0.00161	CcSEcCtD
Fomepizole—Pain—Paclitaxel—kidney cancer	0.000523	0.0016	CcSEcCtD
Fomepizole—CAT—Metabolism—PPAT—kidney cancer	0.000523	0.00118	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GLIPR1—kidney cancer	0.000523	0.00118	CbGpPWpGaD
Fomepizole—Anxiety—Capecitabine—kidney cancer	0.000522	0.00159	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MAPK1—kidney cancer	0.000521	0.00118	CbGpPWpGaD
Fomepizole—Nausea—Dactinomycin—kidney cancer	0.000512	0.00156	CcSEcCtD
Fomepizole—Dizziness—Vincristine—kidney cancer	0.000509	0.00155	CcSEcCtD
Fomepizole—ADH1B—Metabolism—GPC3—kidney cancer	0.000508	0.00115	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GPC3—kidney cancer	0.000508	0.00115	CbGpPWpGaD
Fomepizole—Drowsiness—Doxorubicin—kidney cancer	0.000507	0.00155	CcSEcCtD
Fomepizole—Gastrointestinal pain—Paclitaxel—kidney cancer	0.0005	0.00153	CcSEcCtD
Fomepizole—Diarrhoea—Gemcitabine—kidney cancer	0.0005	0.00152	CcSEcCtD
Fomepizole—ADH1C—Metabolism—CA2—kidney cancer	0.000494	0.00112	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CA2—kidney cancer	0.000494	0.00112	CbGpPWpGaD
Fomepizole—Shock—Capecitabine—kidney cancer	0.000494	0.00151	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—KRAS—kidney cancer	0.000492	0.00111	CbGpPWpGaD
Fomepizole—Tachycardia—Capecitabine—kidney cancer	0.00049	0.00149	CcSEcCtD
Fomepizole—Vomiting—Vincristine—kidney cancer	0.00049	0.00149	CcSEcCtD
Fomepizole—CAT—Metabolism—FH—kidney cancer	0.000486	0.0011	CbGpPWpGaD
Fomepizole—CAT—Metabolism—APRT—kidney cancer	0.000486	0.0011	CbGpPWpGaD
Fomepizole—Rash—Vincristine—kidney cancer	0.000486	0.00148	CcSEcCtD
Fomepizole—Dermatitis—Vincristine—kidney cancer	0.000485	0.00148	CcSEcCtD
Fomepizole—Abdominal pain—Paclitaxel—kidney cancer	0.000484	0.00147	CcSEcCtD
Fomepizole—Body temperature increased—Paclitaxel—kidney cancer	0.000484	0.00147	CcSEcCtD
Fomepizole—Headache—Vincristine—kidney cancer	0.000483	0.00147	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GLIPR1—kidney cancer	0.000481	0.00109	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PPAT—kidney cancer	0.000481	0.00109	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ALAD—kidney cancer	0.000481	0.00109	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ALAD—kidney cancer	0.000481	0.00109	CbGpPWpGaD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000481	0.00109	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—kidney cancer	0.00048	0.00108	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—SLC5A3—kidney cancer	0.000472	0.00107	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ST3GAL2—kidney cancer	0.00047	0.00106	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ST3GAL2—kidney cancer	0.00047	0.00106	CbGpPWpGaD
Fomepizole—Hypotension—Capecitabine—kidney cancer	0.000469	0.00143	CcSEcCtD
Fomepizole—Vomiting—Gemcitabine—kidney cancer	0.000465	0.00142	CcSEcCtD
Fomepizole—Bradycardia—Doxorubicin—kidney cancer	0.000464	0.00141	CcSEcCtD
Fomepizole—Rash—Gemcitabine—kidney cancer	0.000461	0.0014	CcSEcCtD
Fomepizole—Dermatitis—Gemcitabine—kidney cancer	0.00046	0.0014	CcSEcCtD
Fomepizole—ADH1B—Metabolism—ALDH1A1—kidney cancer	0.000459	0.00104	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ALDH1A1—kidney cancer	0.000459	0.00104	CbGpPWpGaD
Fomepizole—Headache—Gemcitabine—kidney cancer	0.000458	0.0014	CcSEcCtD
Fomepizole—Nausea—Vincristine—kidney cancer	0.000458	0.0014	CcSEcCtD
Fomepizole—CAT—Metabolism—GPC3—kidney cancer	0.000457	0.00103	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CA—kidney cancer	0.000452	0.00102	CbGpPWpGaD
Fomepizole—Pharyngitis—Doxorubicin—kidney cancer	0.000452	0.00138	CcSEcCtD
Fomepizole—ADH1A—Metabolism—FH—kidney cancer	0.000448	0.00101	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—APRT—kidney cancer	0.000448	0.00101	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000447	0.00101	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CA2—kidney cancer	0.000445	0.00101	CbGpPWpGaD
Fomepizole—Dyspepsia—Capecitabine—kidney cancer	0.000442	0.00135	CcSEcCtD
Fomepizole—ADH1B—Metabolism—PGK1—kidney cancer	0.00044	0.000995	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—SLC5A3—kidney cancer	0.00044	0.000995	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PGK1—kidney cancer	0.00044	0.000995	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—SLC5A3—kidney cancer	0.00044	0.000995	CbGpPWpGaD
Fomepizole—Visual impairment—Doxorubicin—kidney cancer	0.000439	0.00134	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—kidney cancer	0.000437	0.000988	CbGpPWpGaD
Fomepizole—Decreased appetite—Capecitabine—kidney cancer	0.000436	0.00133	CcSEcCtD
Fomepizole—Nausea—Gemcitabine—kidney cancer	0.000434	0.00132	CcSEcCtD
Fomepizole—CAT—Metabolism—ALAD—kidney cancer	0.000433	0.00098	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—LDHB—kidney cancer	0.000432	0.000976	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—LDHB—kidney cancer	0.000432	0.000976	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—ALDH1A1—kidney cancer	0.000432	0.000975	CbGpPWpGaD
Fomepizole—Pain—Capecitabine—kidney cancer	0.000429	0.00131	CcSEcCtD
Fomepizole—CAT—Metabolism—ST3GAL2—kidney cancer	0.000423	0.000956	CbGpPWpGaD
Fomepizole—Flushing—Doxorubicin—kidney cancer	0.000423	0.00129	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GPC3—kidney cancer	0.000421	0.000951	CbGpPWpGaD
Fomepizole—Diarrhoea—Paclitaxel—kidney cancer	0.000419	0.00128	CcSEcCtD
Fomepizole—CAT—Metabolism—ALDH1A1—kidney cancer	0.000414	0.000934	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—KEAP1—kidney cancer	0.000412	0.000932	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Capecitabine—kidney cancer	0.000411	0.00125	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CA2—kidney cancer	0.000409	0.000925	CbGpPWpGaD
Fomepizole—Dizziness—Paclitaxel—kidney cancer	0.000405	0.00123	CcSEcCtD
Fomepizole—ADH1A—Metabolism—ALAD—kidney cancer	0.000399	0.000901	CbGpPWpGaD
Fomepizole—Abdominal pain—Capecitabine—kidney cancer	0.000397	0.00121	CcSEcCtD
Fomepizole—Body temperature increased—Capecitabine—kidney cancer	0.000397	0.00121	CcSEcCtD
Fomepizole—CAT—Metabolism—PGK1—kidney cancer	0.000396	0.000896	CbGpPWpGaD
Fomepizole—CAT—Metabolism—SLC5A3—kidney cancer	0.000396	0.000896	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ST3GAL2—kidney cancer	0.000389	0.00088	CbGpPWpGaD
Fomepizole—Vomiting—Paclitaxel—kidney cancer	0.000389	0.00119	CcSEcCtD
Fomepizole—CAT—Metabolism—LDHB—kidney cancer	0.000389	0.000879	CbGpPWpGaD
Fomepizole—Dysgeusia—Doxorubicin—kidney cancer	0.000388	0.00118	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDKN2A—kidney cancer	0.000387	0.000875	CbGpPWpGaD
Fomepizole—Rash—Paclitaxel—kidney cancer	0.000386	0.00118	CcSEcCtD
Fomepizole—Dermatitis—Paclitaxel—kidney cancer	0.000385	0.00118	CcSEcCtD
Fomepizole—Back pain—Doxorubicin—kidney cancer	0.000384	0.00117	CcSEcCtD
Fomepizole—Headache—Paclitaxel—kidney cancer	0.000383	0.00117	CcSEcCtD
Fomepizole—ADH1A—Metabolism—ALDH1A1—kidney cancer	0.000381	0.00086	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CA9—kidney cancer	0.000374	0.000846	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CA9—kidney cancer	0.000374	0.000846	CbGpPWpGaD
Fomepizole—Vision blurred—Doxorubicin—kidney cancer	0.000374	0.00114	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—RELA—kidney cancer	0.000373	0.000842	CbGpPWpGaD
Fomepizole—Anaemia—Doxorubicin—kidney cancer	0.000367	0.00112	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—MTOR—kidney cancer	0.000366	0.000826	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PGK1—kidney cancer	0.000365	0.000824	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—SLC5A3—kidney cancer	0.000365	0.000824	CbGpPWpGaD
Fomepizole—Agitation—Doxorubicin—kidney cancer	0.000364	0.00111	CcSEcCtD
Fomepizole—Nausea—Paclitaxel—kidney cancer	0.000363	0.00111	CcSEcCtD
Fomepizole—ADH1A—Metabolism—LDHB—kidney cancer	0.000358	0.000809	CbGpPWpGaD
Fomepizole—Vertigo—Doxorubicin—kidney cancer	0.000356	0.00109	CcSEcCtD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000356	0.000804	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000354	0.000799	CbGpPWpGaD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000351	0.000793	CbGpPWpGaD
Fomepizole—CYP2E1—Tryptophan metabolism—CYP1A1—kidney cancer	0.000348	0.000785	CbGpPWpGaD
Fomepizole—Convulsion—Doxorubicin—kidney cancer	0.000344	0.00105	CcSEcCtD
Fomepizole—Diarrhoea—Capecitabine—kidney cancer	0.000344	0.00105	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDKN1B—kidney cancer	0.000343	0.000775	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—ALDH1A1—kidney cancer	0.000341	0.000771	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CA9—kidney cancer	0.000337	0.000762	CbGpPWpGaD
Fomepizole—Anxiety—Doxorubicin—kidney cancer	0.000336	0.00103	CcSEcCtD
Fomepizole—Dizziness—Capecitabine—kidney cancer	0.000332	0.00101	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—JUN—kidney cancer	0.000327	0.000738	CbGpPWpGaD
Fomepizole—Vomiting—Capecitabine—kidney cancer	0.000319	0.000973	CcSEcCtD
Fomepizole—Shock—Doxorubicin—kidney cancer	0.000318	0.000971	CcSEcCtD
Fomepizole—ADH1B—Metabolism—CRABP1—kidney cancer	0.000318	0.000719	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CRABP1—kidney cancer	0.000318	0.000719	CbGpPWpGaD
Fomepizole—Rash—Capecitabine—kidney cancer	0.000317	0.000965	CcSEcCtD
Fomepizole—Dermatitis—Capecitabine—kidney cancer	0.000316	0.000964	CcSEcCtD
Fomepizole—Tachycardia—Doxorubicin—kidney cancer	0.000316	0.000963	CcSEcCtD
Fomepizole—Headache—Capecitabine—kidney cancer	0.000315	0.000959	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CA9—kidney cancer	0.00031	0.000701	CbGpPWpGaD
Fomepizole—Hypotension—Doxorubicin—kidney cancer	0.000302	0.000922	CcSEcCtD
Fomepizole—Nausea—Capecitabine—kidney cancer	0.000298	0.000909	CcSEcCtD
Fomepizole—ADH1B—Metabolism—ITPR2—kidney cancer	0.000296	0.000669	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ITPR2—kidney cancer	0.000296	0.000669	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000288	0.000651	CbGpPWpGaD
Fomepizole—Somnolence—Doxorubicin—kidney cancer	0.000288	0.000877	CcSEcCtD
Fomepizole—CAT—Metabolism—CRABP1—kidney cancer	0.000287	0.000648	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—VEGFA—kidney cancer	0.000285	0.000645	CbGpPWpGaD
Fomepizole—Dyspepsia—Doxorubicin—kidney cancer	0.000285	0.000869	CcSEcCtD
Fomepizole—Decreased appetite—Doxorubicin—kidney cancer	0.000281	0.000858	CcSEcCtD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000281	0.000635	CbGpPWpGaD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000277	0.000627	CbGpPWpGaD
Fomepizole—Pain—Doxorubicin—kidney cancer	0.000277	0.000844	CcSEcCtD
Fomepizole—ADH1C—Metabolism—ACHE—kidney cancer	0.00027	0.00061	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTT1—kidney cancer	0.00027	0.00061	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ACHE—kidney cancer	0.00027	0.00061	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTT1—kidney cancer	0.00027	0.00061	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—MAPK3—kidney cancer	0.00027	0.00061	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ITPR2—kidney cancer	0.000266	0.000602	CbGpPWpGaD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000265	0.000599	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000265	0.000807	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CRABP1—kidney cancer	0.000264	0.000596	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—MAPK1—kidney cancer	0.000257	0.00058	CbGpPWpGaD
Fomepizole—Body temperature increased—Doxorubicin—kidney cancer	0.000256	0.00078	CcSEcCtD
Fomepizole—Abdominal pain—Doxorubicin—kidney cancer	0.000256	0.00078	CcSEcCtD
Fomepizole—ADH1B—Metabolism—SCARB1—kidney cancer	0.000255	0.000577	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—SCARB1—kidney cancer	0.000255	0.000577	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—GSTT1—kidney cancer	0.000254	0.000573	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS1—kidney cancer	0.000253	0.000571	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS1—kidney cancer	0.000253	0.000571	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—SLC5A5—kidney cancer	0.000249	0.000562	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PSMD7—kidney cancer	0.000248	0.00056	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PSMD7—kidney cancer	0.000248	0.00056	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ITPR2—kidney cancer	0.000245	0.000554	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ACHE—kidney cancer	0.000243	0.000549	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTT1—kidney cancer	0.000243	0.000549	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—SLC2A1—kidney cancer	0.00024	0.000543	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—PTGS1—kidney cancer	0.000238	0.000537	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—BCHE—kidney cancer	0.000235	0.000531	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—BCHE—kidney cancer	0.000235	0.000531	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—SLC5A5—kidney cancer	0.000232	0.000525	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—SLC5A5—kidney cancer	0.000232	0.000525	CbGpPWpGaD
Fomepizole—CAT—Metabolism—SCARB1—kidney cancer	0.00023	0.00052	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000228	0.000515	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS1—kidney cancer	0.000228	0.000515	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—SLC2A1—kidney cancer	0.000224	0.000507	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—SLC2A1—kidney cancer	0.000224	0.000507	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTT1—kidney cancer	0.000224	0.000505	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ACHE—kidney cancer	0.000224	0.000505	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PSMD7—kidney cancer	0.000223	0.000505	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—EGR1—kidney cancer	0.000223	0.000504	CbGpPWpGaD
Fomepizole—Diarrhoea—Doxorubicin—kidney cancer	0.000221	0.000675	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—TP53—kidney cancer	0.000216	0.000487	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000215	0.000486	CbGpPWpGaD
Fomepizole—Dizziness—Doxorubicin—kidney cancer	0.000214	0.000653	CcSEcCtD
Fomepizole—CAT—Metabolism—BCHE—kidney cancer	0.000212	0.000478	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—SCARB1—kidney cancer	0.000212	0.000478	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS1—kidney cancer	0.00021	0.000474	CbGpPWpGaD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.00021	0.000473	CbGpPWpGaD
Fomepizole—CAT—Metabolism—SLC5A5—kidney cancer	0.000209	0.000473	CbGpPWpGaD
Fomepizole—Vomiting—Doxorubicin—kidney cancer	0.000206	0.000627	CcSEcCtD
Fomepizole—ADH1A—Metabolism—PSMD7—kidney cancer	0.000206	0.000464	CbGpPWpGaD
Fomepizole—Rash—Doxorubicin—kidney cancer	0.000204	0.000622	CcSEcCtD
Fomepizole—Dermatitis—Doxorubicin—kidney cancer	0.000204	0.000622	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—kidney cancer	0.000203	0.000459	CbGpPWpGaD
Fomepizole—Headache—Doxorubicin—kidney cancer	0.000203	0.000618	CcSEcCtD
Fomepizole—CAT—Metabolism—SLC2A1—kidney cancer	0.000202	0.000456	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTT1—kidney cancer	0.0002	0.000453	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—GSTP1—kidney cancer	0.0002	0.000453	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—BCHE—kidney cancer	0.000195	0.00044	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—SLC5A5—kidney cancer	0.000192	0.000435	CbGpPWpGaD
Fomepizole—Nausea—Doxorubicin—kidney cancer	0.000192	0.000586	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—PTGS1—kidney cancer	0.000188	0.000424	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTP1—kidney cancer	0.000187	0.000423	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTP1—kidney cancer	0.000187	0.000423	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—SLC2A1—kidney cancer	0.000186	0.00042	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—GSTM1—kidney cancer	0.000184	0.000416	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ABCB1—kidney cancer	0.000177	0.0004	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ABCB1—kidney cancer	0.000177	0.0004	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—GSTP1—kidney cancer	0.000176	0.000397	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTM1—kidney cancer	0.000172	0.000388	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTM1—kidney cancer	0.000172	0.000388	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00017	0.000384	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTP1—kidney cancer	0.000168	0.000381	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP1A1—kidney cancer	0.000163	0.000368	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP1A1—kidney cancer	0.000163	0.000368	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—GSTM1—kidney cancer	0.000162	0.000365	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ABCB1—kidney cancer	0.000159	0.00036	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTP1—kidney cancer	0.000155	0.00035	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTM1—kidney cancer	0.000155	0.00035	CbGpPWpGaD
Fomepizole—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.000155	0.00035	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—CYP1A1—kidney cancer	0.000153	0.000346	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ABCB1—kidney cancer	0.000147	0.000332	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP1A1—kidney cancer	0.000147	0.000332	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTM1—kidney cancer	0.000142	0.000322	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTP1—kidney cancer	0.000139	0.000314	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTP1—kidney cancer	0.000137	0.00031	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CYP1A1—kidney cancer	0.000135	0.000305	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ACY1—kidney cancer	0.000135	0.000304	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTM1—kidney cancer	0.000128	0.000288	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTM1—kidney cancer	0.000126	0.000285	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—POMC—kidney cancer	0.000122	0.000275	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—POMC—kidney cancer	0.000122	0.000275	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—CYP1A1—kidney cancer	0.000121	0.000273	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000119	0.00027	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PDHB—kidney cancer	0.000115	0.000259	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—POMC—kidney cancer	0.000114	0.000258	CbGpPWpGaD
Fomepizole—CAT—Metabolism—POMC—kidney cancer	0.000109	0.000247	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CCBL1—kidney cancer	0.000108	0.000243	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ACY1—kidney cancer	0.000106	0.000241	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—POMC—kidney cancer	0.000101	0.000228	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS2—kidney cancer	9.69e-05	0.000219	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS2—kidney cancer	9.69e-05	0.000219	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PPAT—kidney cancer	9.34e-05	0.000211	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GLIPR1—kidney cancer	9.34e-05	0.000211	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PDHB—kidney cancer	9.05e-05	0.000205	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—POMC—kidney cancer	9.02e-05	0.000204	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS2—kidney cancer	8.73e-05	0.000197	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—FH—kidney cancer	8.68e-05	0.000196	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—APRT—kidney cancer	8.68e-05	0.000196	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CCBL1—kidney cancer	8.51e-05	0.000192	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTEN—kidney cancer	8.45e-05	0.000191	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTEN—kidney cancer	8.45e-05	0.000191	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GPC3—kidney cancer	8.16e-05	0.000184	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS2—kidney cancer	8.03e-05	0.000181	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CA2—kidney cancer	7.94e-05	0.000179	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ALAD—kidney cancer	7.74e-05	0.000175	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTEN—kidney cancer	7.61e-05	0.000172	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ST3GAL2—kidney cancer	7.55e-05	0.000171	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ALDH1A1—kidney cancer	7.38e-05	0.000167	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GLIPR1—kidney cancer	7.38e-05	0.000167	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PPAT—kidney cancer	7.38e-05	0.000167	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PGK1—kidney cancer	7.08e-05	0.00016	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—SLC5A3—kidney cancer	7.08e-05	0.00016	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTEN—kidney cancer	7e-05	0.000158	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—LDHB—kidney cancer	6.94e-05	0.000157	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—FH—kidney cancer	6.86e-05	0.000155	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—APRT—kidney cancer	6.86e-05	0.000155	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GPC3—kidney cancer	6.45e-05	0.000146	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CA2—kidney cancer	6.27e-05	0.000142	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ALAD—kidney cancer	6.11e-05	0.000138	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CA9—kidney cancer	6.02e-05	0.000136	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ST3GAL2—kidney cancer	5.97e-05	0.000135	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CA—kidney cancer	5.96e-05	0.000135	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CA—kidney cancer	5.96e-05	0.000135	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ALDH1A1—kidney cancer	5.83e-05	0.000132	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PGK1—kidney cancer	5.59e-05	0.000126	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—SLC5A3—kidney cancer	5.59e-05	0.000126	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—LDHB—kidney cancer	5.48e-05	0.000124	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CA—kidney cancer	5.37e-05	0.000121	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CRABP1—kidney cancer	5.12e-05	0.000116	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CA—kidney cancer	4.94e-05	0.000112	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ITPR2—kidney cancer	4.76e-05	0.000107	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CA9—kidney cancer	4.75e-05	0.000107	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTT1—kidney cancer	4.34e-05	9.8e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ACHE—kidney cancer	4.34e-05	9.8e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—SCARB1—kidney cancer	4.11e-05	9.28e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS1—kidney cancer	4.06e-05	9.18e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CRABP1—kidney cancer	4.04e-05	9.14e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PSMD7—kidney cancer	3.99e-05	9.01e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—BCHE—kidney cancer	3.78e-05	8.54e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ITPR2—kidney cancer	3.76e-05	8.49e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—SLC5A5—kidney cancer	3.73e-05	8.43e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—SLC2A1—kidney cancer	3.6e-05	8.14e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ACHE—kidney cancer	3.43e-05	7.75e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTT1—kidney cancer	3.43e-05	7.75e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—SCARB1—kidney cancer	3.24e-05	7.33e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS1—kidney cancer	3.21e-05	7.26e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PSMD7—kidney cancer	3.15e-05	7.12e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTP1—kidney cancer	3.01e-05	6.79e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—BCHE—kidney cancer	2.99e-05	6.75e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—SLC5A5—kidney cancer	2.95e-05	6.66e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.85e-05	6.44e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ABCB1—kidney cancer	2.85e-05	6.43e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTM1—kidney cancer	2.76e-05	6.24e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP1A1—kidney cancer	2.62e-05	5.92e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTP1—kidney cancer	2.38e-05	5.37e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ABCB1—kidney cancer	2.25e-05	5.08e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTM1—kidney cancer	2.18e-05	4.93e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP1A1—kidney cancer	2.07e-05	4.68e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—POMC—kidney cancer	1.95e-05	4.41e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS2—kidney cancer	1.56e-05	3.52e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—POMC—kidney cancer	1.54e-05	3.49e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTEN—kidney cancer	1.36e-05	3.07e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS2—kidney cancer	1.23e-05	2.78e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTEN—kidney cancer	1.07e-05	2.43e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CA—kidney cancer	9.58e-06	2.17e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CA—kidney cancer	7.57e-06	1.71e-05	CbGpPWpGaD
